BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

211 related articles for article (PubMed ID: 22947849)

  • 1. Metabolic regulation, mitochondria and the life-prolonging effect of rapamycin: a mini-review.
    Pan Y; Nishida Y; Wang M; Verdin E
    Gerontology; 2012; 58(6):524-30. PubMed ID: 22947849
    [TBL] [Abstract][Full Text] [Related]  

  • 2. TORC1 signaling inhibition by rapamycin and caffeine affect lifespan, global gene expression, and cell proliferation of fission yeast.
    Rallis C; Codlin S; Bähler J
    Aging Cell; 2013 Aug; 12(4):563-73. PubMed ID: 23551936
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The role of the TOR pathway in mediating the link between nutrition and longevity.
    Lushchak O; Strilbytska O; Piskovatska V; Storey KB; Koliada A; Vaiserman A
    Mech Ageing Dev; 2017 Jun; 164():127-138. PubMed ID: 28315697
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inhibition of TORC1 signaling and increased lifespan: gained in translation?
    Rallis C; Bähler J
    Aging (Albany NY); 2013 May; 5(5):335-6. PubMed ID: 23715437
    [No Abstract]   [Full Text] [Related]  

  • 5. Extension of chronological life span by reduced TOR signaling requires down-regulation of Sch9p and involves increased mitochondrial OXPHOS complex density.
    Pan Y; Shadel GS
    Aging (Albany NY); 2009 Jan; 1(1):131-45. PubMed ID: 20157595
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Target of Rapamycin (TOR) Regulates Growth in Response to Nutritional Signals.
    Weisman R
    Microbiol Spectr; 2016 Oct; 4(5):. PubMed ID: 27763256
    [TBL] [Abstract][Full Text] [Related]  

  • 7. mTORC2 takes the longevity stAGE.
    Lamming DW
    Oncotarget; 2014 Sep; 5(17):7214-5. PubMed ID: 25294787
    [No Abstract]   [Full Text] [Related]  

  • 8. TOR signaling and rapamycin influence longevity by regulating SKN-1/Nrf and DAF-16/FoxO.
    Robida-Stubbs S; Glover-Cutter K; Lamming DW; Mizunuma M; Narasimhan SD; Neumann-Haefelin E; Sabatini DM; Blackwell TK
    Cell Metab; 2012 May; 15(5):713-24. PubMed ID: 22560223
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Rapamycin: An InhibiTOR of Aging Emerges From the Soil of Easter Island.
    Arriola Apelo SI; Lamming DW
    J Gerontol A Biol Sci Med Sci; 2016 Jul; 71(7):841-9. PubMed ID: 27208895
    [TBL] [Abstract][Full Text] [Related]  

  • 10. TOR complex 2 (TORC2) in Dictyostelium suppresses phagocytic nutrient capture independently of TORC1-mediated nutrient sensing.
    Rosel D; Khurana T; Majithia A; Huang X; Bhandari R; Kimmel AR
    J Cell Sci; 2012 Jan; 125(Pt 1):37-48. PubMed ID: 22266904
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Rapamycin enhances survival in a Drosophila model of mitochondrial disease.
    Wang A; Mouser J; Pitt J; Promislow D; Kaeberlein M
    Oncotarget; 2016 Dec; 7(49):80131-80139. PubMed ID: 27741510
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Reduced mammalian target of rapamycin activity facilitates mitochondrial retrograde signaling and increases life span in normal human fibroblasts.
    Lerner C; Bitto A; Pulliam D; Nacarelli T; Konigsberg M; Van Remmen H; Torres C; Sell C
    Aging Cell; 2013 Dec; 12(6):966-77. PubMed ID: 23795962
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Duration of rapamycin treatment has differential effects on metabolism in mice.
    Fang Y; Westbrook R; Hill C; Boparai RK; Arum O; Spong A; Wang F; Javors MA; Chen J; Sun LY; Bartke A
    Cell Metab; 2013 Mar; 17(3):456-62. PubMed ID: 23473038
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effective targeting of colorectal cancer cells using TORC1/2 kinase inhibitors in vitro and in vivo.
    Zhang J; Jiang W; Liu W; Wu JJ; Song L; Cheng JX; Yao M; Yang LP; Yao DF
    Future Oncol; 2016 Feb; 12(4):515-24. PubMed ID: 26776341
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Assessment of mitochondrial biogenesis and mTORC1 signaling during chronic rapamycin feeding in male and female mice.
    Drake JC; Peelor FF; Biela LM; Watkins MK; Miller RA; Hamilton KL; Miller BF
    J Gerontol A Biol Sci Med Sci; 2013 Dec; 68(12):1493-501. PubMed ID: 23657975
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Rheb and mammalian target of rapamycin in mitochondrial homoeostasis.
    Groenewoud MJ; Zwartkruis FJ
    Open Biol; 2013 Dec; 3(12):130185. PubMed ID: 24352740
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A mitochondrial ATP synthase subunit interacts with TOR signaling to modulate protein homeostasis and lifespan in Drosophila.
    Sun X; Wheeler CT; Yolitz J; Laslo M; Alberico T; Sun Y; Song Q; Zou S
    Cell Rep; 2014 Sep; 8(6):1781-1792. PubMed ID: 25220459
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Regulation of yeast chronological life span by TORC1 via adaptive mitochondrial ROS signaling.
    Pan Y; Schroeder EA; Ocampo A; Barrientos A; Shadel GS
    Cell Metab; 2011 Jun; 13(6):668-78. PubMed ID: 21641548
    [TBL] [Abstract][Full Text] [Related]  

  • 19. TORC2 Structure and Function.
    Gaubitz C; Prouteau M; Kusmider B; Loewith R
    Trends Biochem Sci; 2016 Jun; 41(6):532-545. PubMed ID: 27161823
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Angiotensin II blockade: how its molecular targets may signal to mitochondria and slow aging. Coincidences with calorie restriction and mTOR inhibition.
    de Cavanagh EM; Inserra F; Ferder L
    Am J Physiol Heart Circ Physiol; 2015 Jul; 309(1):H15-44. PubMed ID: 25934099
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.